Engineering an in vivo charging station for CAR-redirected invariant natural killer T cells to enhance cancer therapy

Li YR, Nan H, Liu Z, Fang Y, Zhu Y, Lyu Z, Shao Z, Zhu E, Zhang B, Yang Y, Shen X, Chen Y, Hsiai T, Yang L, Li S. Engineering an in vivo charging station for CAR-redirected invariant natural killer T cells to enhance cancer therapy. Nat Biomed Eng. 2026 Mar 17. doi: 10.1038/s41551-026-01629-3. Epub ahead of print. PMID: 41845089.


Related Posts